Source map — AbbVie's Cerevel buyout delivers as FDA gives go-ahead to 1st-in-class Juvmo in Parkinson's disease
Every domain this feed has drawn corroborated signal from. We store facts and short excerpts and link back to originals — never republished article bodies.
| Source | Type | Trust |
|---|---|---|
| Reuters | news | 60% |
| WGN-TV | news | 60% |
| Medscape | news | 60% |
| Ynetnews | news | 60% |
| Crain's Chicago Business | news | 60% |
| FOX 8 News | news | 60% |
| Yahoo Finance | news | 60% |
| MedPage Today | news | 60% |
| BioSpace | news | 60% |
| fiercepharma.com | news | 60% |
| www.biospace.com | news | 50% |
| news.abbvie.com | news | 50% |
| pharmaphorum.com | news | 50% |
| finance.yahoo.com | news | 50% |
| en.wikipedia.org | news | 50% |
| careers.abbvie.com | news | 50% |
| www.pharmajournalist.com | news | 50% |
| bobby.ai | news | 50% |
| www.pharmacy.biz | news | 50% |